Press release: Qaelum – Belgian expert in medical quality monitoring & analysis – opens New York offices to kick off US business as part of its worldwide expansion

After a 2M € internal capital round and appointing key experts, Qaelum NV – KULeuven-spinoff focusing on total quality monitoring in medical imaging – opens a new subsidiary in the United States. This milestone comes only months after strengthening Qaelum’s corporate & sales structure to support its fast global expansion. Working from the Qaelum offices in New York city, the sales team will target radiology and other departments in American and Canadian hospitals.

Belgian innovator ready for the US market

Qaelum is ready to take the next step. After acquiring market leadership in Belgium, Qaelum has implemented its software solutions in 16 European countries and also in the Middle East. In the process, agreements have been set up with FUJIFILM and AGFA Healthcare to operate as Qaelum distributors with sales teams promoting and selling DOSE internationally.

After the capital increase last August, Qaelum extended its local presence in key EMEA regions and started expansion overseas. Important in this regard is the appointment of Luc Colle as VP Global Sales. And now QAELUM officially opens a location in New York at the offices of BelCham in Manhattan, New York. Starting at the East-coast of the US was a specific choice for Qaelum, as it holds a high density of larger hospitals and it gives easy access to major Canadian cities for continued prospection in the region. Also interesting: according to Micro Market Monitor, the U.S. radiation dose management market is projected to grow until 2020 with an compound annual growth rate of nearly 50%.

Luc Colle, VP Global Sales QAELUM: “After receiving regulator’s approval for Qaelum software in the US and Canada, we envisaged to start the overseas territorial expansion of our sales activities. Similar to the EU, US legislation focuses on patient safety and quality. This means that there is a large and fast growing market for Qaelum. The opening of the New York office marks the first step in our overseas expansion. Our presence there is official now, allowing us to set up reference sites at US hospitals, roll out our primary prospection and attract partners.”

Focus on quality & patient safety

With regulations focusing more on quality and patient safety, together with a growing awareness of medical radiation and associated risks, Qaelum has made it its mission to optimize quality, safety and efficiency in radiology departments (and hospitals in general). Qaelum's DOSE software solution enables hospitals to monitor and optimize the radiation dose applied as part of a range of medical applications (incl. mammography), and streamlines the operational efficiency of radiology and other departments. Increased safety is advantageous for the patients and the hospitals, but the health system in hospitals also yields financial savings when radiology related services operate more efficiently.

Jurgen Jacobs, QAELUM CEO: “Our unique offering converts the burden of lengthy manual quality evaluations into a valuable tool for continuous quality improvement. I am very excited that we can now offer these services for hospitals in the US and Canada as well. ”

ABOUT QAELUM N.V.

QAELUM is a high-tech spin-off company of the University Hospitals Leuven. Based on more than 15 years of quality assurance experience in an academic environment as well as in the field, QAELUM is seen as the preferred partner when it comes to medical imaging quality control. Leading hospital groups share our vision of a global system for quality assurance, which realises optimal use of radiation and guarantees maximum safety for patients and staff. At the same time, they acquire a more detailed overview of and deeper insights into all quality related aspects.

Passionate about solving real world problems, QAELUM focuses on the development and deployment of highly innovative solutions and services to resolve the daily problems of every medical imaging professional. Ranging from automated quality control in nationwide breast screening programs to optimised solutions for local patient dose monitoring, QAELUM has solutions for all these problems regardless of the scale. The combination of advanced software tools and expert knowledge in the field, makes the innovative solutions offering a preferred choice for healthcare professionals.

pdf of English press release

Persbericht in het Nederlands

Communiqué de presse en Francais

Pressemitteilung auf Deutsch

Comunicado de prensa en Español

Contact